Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 56.66
-0.95 (-1.65%)
Mar 9, 2026, 4:00 PM EDT
Bide Pharmatech Market Cap
Bide Pharmatech has a market cap or net worth of 5.13 billion as of March 10, 2026. Its market cap has increased by 13.83% in one year.
Market Cap
5.13B
Enterprise Value
4.21B
Revenue
1.32B
Ranking
n/a
PE Ratio
34.01
Stock Price
56.66
Market Cap Chart
Since October 11, 2022, Bide Pharmatech's market cap has increased from 4.38B to 5.13B, an increase of 17.18%. That is a compound annual growth rate of 4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 5.13B | -2.51% |
| Dec 31, 2025 | 5.26B | 21.13% |
| Dec 31, 2024 | 4.34B | -13.91% |
| Dec 29, 2023 | 5.04B | -5.42% |
| Dec 30, 2022 | 5.33B | 21.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jianmin Pharmaceutical Group | 4.84B |
| Newland Pharmaceutical | 4.83B |
| Ningbo Menovo Pharmaceutical | 4.98B |
| Zhejiang Yatai Pharmaceutical | 4.98B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.75B |
| Nanjing Hicin Pharmaceutical | 5.03B |
| Luoxin Pharmaceuticals Group Stock | 5.10B |
| Tibet Weixinkang Medicine | 4.67B |